By combining a short-acting Growth Hormone-Releasing Hormone (GHRH) analog with a highly selective Growth Hormone Secretagogue Receptor (GHSR) agonist, researchers can evaluate physiologic GH pulsatility, receptor interactions, endocrine signaling, and downstream biomarker responses under controlled laboratory conditions
CAS No.: 2381089-83-2 Retatrutide Chemical Structure Molecular formula:C 221 H 342 N 46 O 68 Molecular weight: 4731.33 Patent period: Compound: 2026 Composition: 2029 Dositive specifications: Injection (type II diabetes, OZEMPIC): Oral tablets: Injection : Products are for laboratory research use only
Following the patent expiry of Ozempic, Wegovy, and Rybelsus on March 20, 2026, generic Semaglutide is now available in India, China, Canada, Brazil, and a few other countries
How Semaglutide Works in the Body Semaglutide is part of a class of drugs called GLP-1 receptor agonists
Research indicates that this peptide may promote healing in muscles, ligaments, and the gastrointestinal tract by enhancing natural growth and repair pathways